Scott Love concentrates his practice in the areas of products liability, personal injury, wrongful death, mass tort litigation and class action litigation. Over the course of his career, Scott has distinguished himself as one of the leading mass tort and trial lawyers in the country. Currently, Scott is one of only a handful of lawyers in the United States to obtain multiple multi-million dollar verdicts in pharmaceutical and medical device cases.
In addition to his active trial practice, Scott has been selected to leadership roles in numerous consumer class actions and mass tort cases, including, insurance cases, oil & gas cases and various pharmaceutical cases such as Trasylol, Paxil, Accutane, Topamax, Zoloft, and Transvaginal Mesh.
Scott was recently appointed as national counsel on the Plaintiffs' Steering Committee for the Transvaginal Mesh federal Multi-District litigation pending in West Virginia by the Honorable Judge Goodwin. Scott currently serves on the Plaintiffs' Steering Committee for the following MDLs:
- In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325
- In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2187
- In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2327
- In Re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation, MDL No. 2326
Scott was also one of the leading attorneys in the national Trasylol litigation which was transferred to the Southern District of Florida. Scott was honored with the appointment of co-lead counsel of the Plaintiff's Steering Committee by the Honorable Donald Middlebrooks in May 2008. As co-lead counsel of the PSC, Scott was responsible for coordinating the overall litigation strategy which has successfully resulted in the settlement of all of the cases pending across the country.
As a trial lawyer, Scott's accomplishments speak for themselves: Most recently, Scott obtained an 18.5 million dollar verdict as lead counsel on behalf of four clients who suffered injuries as a result of the Obtryx Sling System. The Obtryx sling is a device manufactured by Boston Scientific Corp. for the treatment of stress urinary incontinence. This is the largest compensatory verdict against any mesh manufacturer for the treatment of stress urinary incontinence. (Blankenship et al v. Boston Scientific Corp., WV, MDL 2326).
As lead counsel in the first Topamax birth defect case to be tried in the country, Scott obtained a 4.02 million dollar verdict (Czimmer v. Janssen, Philadelphia Court of Common Pleas). After hearing the evidence in the Czimmer case, the jury deliberated for less than 40 minutes before returning their verdict. This was followed three weeks later with an 11 million dollar verdict in the second Topamax birth defect case. (Powell v. Janssen, Philadelphia Court of Common Pleas). One week into the third trial, Janssen settled all of his firm's Topamax birth defect cases. (Brown v. Janssen, Philadelphia Court of Common Pleas). Topamax is a medication used to treat migraines and epilepsy. It has long been recognized by Janssen that Topamax could cause a wide variety of birth defects. Even though the company knew about these side effects, they failed to warn physicians and patients until the FDA forced them to change their label in 2011.
Scott, along with two colleagues, obtained a $2.5 million dollar verdict in the case of Kilker v. GSK, tried in Philadelphia, PA (October 2009) for injuries sustained by their minor client in the Paxil Birth Defect Litigation.
In addition to his active trial practice, Scott regularly speaks on topics involving litigation and trial strategies and trends, including topics such as:
- Products Liability
- Expert Discovery
- Pharmaceutical Litigation
- Catastrophic Birth Injury Cases
- Cross-Examination of Expert Witnesses
Scott has been recognized as one of the top 100 trial lawyers in the country by both the National Trial Lawyers Association and Americas Top 100 Attorneys. He is a member in the American Board of Trial Advocates (Houston Chapter). Scott is rated "AV-Preeminent" by Martindale Hubble, the highest peer review rating for legal ability and ethical standards. Since 2006, Scott has been recognized every year by his peers as a Super Lawyer (A Thomson Reuters service). This honor is given to less than 5% of all attorneys in the State of Texas.
Areas of Practice
- Products Liability
- Pharmaceutical Litigation
- Catastrophic Injury Cases
- U.S. District Court Southern District of Texas
- U.S. District Court Eastern District of Texas
- U.S. District Court Northern District of Texas
- U.S. District Court Western District of Texas
- U.S. District Court Western District of Arkansas
- U.S. District Court Eastern District of Arkansas
- U.S. Court of Appeals 3rd Circuit
- U.S. Court of Appeals 5th Circuit
- University of Houston Law Center, Houston, Texas
- J.D. - 1997
- University of Houston, Houston, Texas
- B.A. cum laude - 1993
- Honors: With Honors
- Major: History
Honors and Awards
- Americas Top 100 Attorneys- Lifetime Member
- The National Trial Lawyers Association- Top 100 Trial Lawyer
- Recognized by his Peers as a Super Lawyer (A Thomson Reuters Service), 2006 - Present
- Named one of Houston's Top Lawyers, 2007 - 2011
- Houston's Lawyers on the Fast Track as Presented by H Texas Magazine, 2006 - 2011
Professional Associations and Memberships
- American Board of Trial Advocates, Houston Chapter, Member
- Houston Bar Association
- Houston Trial Lawyers Association
- Texas Trial Lawyers Association
- American Association of Justice
- Pennsylvania Trial Lawyers Association